Inari Medical 

$79.97
36
+$0.04+0.05% Tuesday 20:59

Statistics

Day High
79.97
Day Low
79.97
52W High
79.99
52W Low
36.73
Volume
2,356,692
Avg. Volume
2,317,225
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

4MarExpected
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-0.38
-0.24
-0.09
0.05
Expected EPS
-0.04055
Actual EPS
N/A

Financials

-3.53%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
132.09MRevenue
-4.67MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NARI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Penumbra
PEN
Mkt Cap8.87B
Penumbra directly competes with Inari Medical in the market for devices used in thrombectomy and embolization procedures, particularly in treating pulmonary embolism and deep vein thrombosis.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific competes with Inari Medical through its interventional cardiology and peripheral interventions products, including devices for vascular embolization and thrombectomy.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a range of vascular devices, competing in areas overlapping with Inari Medical's focus, especially in treatments involving catheter-based procedures.
Medtronic
MDT
Mkt Cap116.33B
Medtronic competes with Inari Medical in the broader market for medical devices used in endovascular therapies, including products for the treatment of venous diseases.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical device segment, competes in the vascular surgery and interventional radiology sectors, areas relevant to Inari Medical's product offerings.
Sanara MedTech
SMTI
Mkt Cap258.08M
Sanara MedTech offers products in wound and skin care that can be adjunctive to the vascular treatments Inari Medical focuses on, positioning them as indirect competitors.
Angiodynamic
ANGO
Mkt Cap487.39M
AngioDynamics produces medical, surgical, and diagnostic devices that compete with Inari Medical's offerings, especially in the venous disease treatment market.
ICU Medical
ICUI
Mkt Cap3.03B
ICU Medical competes with Inari Medical in the critical care space, offering products that can be used in conjunction with or as alternatives to Inari's devices in vascular access and therapy.
Baxter International
BAX
Mkt Cap9.49B
Baxter International competes in the broader healthcare and medical device market, with products that can intersect with the care pathways Inari Medical's devices are used in.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet, primarily known for orthopedic devices, has expanded into areas that can compete with Inari Medical, especially in the surgical and post-surgical care sectors.

About

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Show more...
CEO
Mr. Kevin Strange
Employees
1300
Country
US
ISIN
US45332Y1091

Listings

0 Comments

Share your thoughts

FAQ

What is Inari Medical stock price today?
The current price of NARI is $79.97 USD — it has increased by +0.05% in the past 24 hours. Watch Inari Medical stock price performance more closely on the chart.
What is Inari Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Inari Medical stocks are traded under the ticker NARI.
What is Inari Medical revenue for the last year?
Inari Medical revenue for the last year amounts to 132.09M USD.
What is Inari Medical net income for the last year?
NARI net income for the last year is -4.67M USD.
How many employees does Inari Medical have?
As of April 04, 2026, the company has 1,300 employees.
In which sector is Inari Medical located?
Inari Medical operates in the Health Care sector.
When did Inari Medical complete a stock split?
Inari Medical has not had any recent stock splits.
Where is Inari Medical headquartered?
Inari Medical is headquartered in Irvine, US.